Company / Operating Cash Flow
PANACEA LIFE SCIENCES HOLDINGS, INC. Operating Cash Flow History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$1.5M
FY2023
5-year range
-$7.6M / -$1.5M
FY2019-FY2023
Trend
+36.5%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has increased for 3 consecutive years, from -$8M in FY2020 to -$2M in FY2023.
Based on SEC 10-K filings.
-$2M in FY2023.
Improved from -$4M to -$2M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- PANACEA LIFE SCIENCES HOLDINGS, INC.'s operating cash flow has grown for 3 consecutive years.
- In FY2023, operating cash flow increased 36.5% year-over-year.
- Peak operating cash flow was recorded in FY2018.
- Lowest operating cash flow in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$1.5M | +36.5% |
| FY2022 | -$2.4M | +38.8% |
| FY2021 | -$3.9M | +48.7% |
| FY2020 | -$7.6M | -33.1% |
| FY2019 | -$5.7M | -1133.8% |
| FY2018 | -$465.8K | +62.3% |
| FY2017 | -$1.2M | -38.6% |
| FY2016 | -$891.0K | -39.2% |
| FY2015 | -$640.0K | - |
As of FY2023 · SEC Form 10-K · Last checked Jun 29, 2026